Anaergia Inc.
ANRGF
$0.17
$0.1591,445.46%
| Weiss Ratings | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.46 | |||
| Price History | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -95.00% | |||
| 30-Day Total Return | -94.20% | |||
| 60-Day Total Return | -93.20% | |||
| 90-Day Total Return | -93.76% | |||
| Year to Date Total Return | -93.96% | |||
| 1-Year Total Return | -98.90% | |||
| 2-Year Total Return | -99.85% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -99.26% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.49 | |||
| 52-Week Low Price | $0.16 | |||
| 52-Week Low Price (Date) | Jan 24, 2024 | |||
| 52-Week High Price (Date) | Jun 16, 2023 | |||
| Valuation | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 35.35M | |||
| Enterprise Value | 168.73M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.21 | |||
| Earnings Per Share Growth | 867.22% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.13 | |||
| Price/Book (Q) | -0.88 | |||
| Enterprise Value/Revenue (TTM) | 1.48 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -3.50 | |||
| Enterprise Value/EBIT | -3.23 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 65.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905-766-3333 | |||
| Address | 4210 South Service Road Burlington, ON L7L 4X5 | |||
| Website | www.anaergia.com | |||
| Country | Canada | |||
| Year Founded | 2007 | |||
| Profitability | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -45.92% | |||
| Profit Margin | -126.52% | |||
| Management Effectiveness | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -7.22% | |||
| Return on Equity | -- | |||
| Income Statement | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 113.93M | |||
| Total Revenue (TTM) | 113.93M | |||
| Revenue Per Share | $1.75 | |||
| Gross Profit (TTM) | 13.03M | |||
| EBITDA (TTM) | -48.33M | |||
| EBIT (TTM) | -52.32M | |||
| Net Income (TTM) | -144.15M | |||
| Net Income Avl. to Common (TTM) | -144.15M | |||
| Total Revenue Growth (Q YOY) | -26.65% | |||
| Earnings Growth (Q YOY) | -596.19% | |||
| EPS Diluted (TTM) | -2.21 | |||
| EPS Diluted Growth (Q YOY) | -571.14% | |||
| Balance Sheet | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.88M | |||
| Cash Per Share (Q) | $0.32 | |||
| Total Current Assets (Q) | 106.75M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 85.67M | |||
| Current Ratio (Q) | 1.125 | |||
| Book Value Per Share (Q) | -$0.25 | |||
| Total Assets (Q) | 240.16M | |||
| Total Current Liabilities (Q) | 94.88M | |||
| Total Debt (Q) | 54.38M | |||
| Total Liabilities (Q) | 154.49M | |||
| Total Common Equity (Q) | -16.29M | |||
| Cash Flow | ANRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -62.75M | |||
| Cash from Financing (TTM) | 54.26M | |||
| Net Change in Cash (TTM) | -60.60M | |||
| Levered Free Cash Flow (TTM) | -64.61M | |||
| Cash from Operations (TTM) | -55.50M | |||
